Evaluation of Der p 10 in a Cohort of European Children: Role of Molecular Diagnostics and Clinical Features

Table 5

Comparison of clinical characteristics of the population sensitized to Der p 10 and Der p 23 and Der p 1 or Der p 2.

	Asthmatics	Atopic dermatitis	Urticaria	Rhinitics	Anaphylaxis
Patients Der p1/2 sensitized	14 (10.4%)	54 (40.3%)	69 (51.5%)	41 (30.6%)	13 (9.7%)
Der p 10 sensitized	17 (73.9%);	12 (52.2%)	9 (39.1%)	9 (39.1%)	19 (89.6%);
Der p 23 sensitized	14 (66.7%);	4 (19%)	9 (42.9%)	12 (57.1%)	2 (9.5%)
Der p 1-2-10 sensitized	11 (78.6%);	7 (50%)	5 (35.7%)	4 (28.6%)	11 (78.6%);
Der p 1-2-23 sensitized	11 (64.7%);	3 (17.6%)	8 (47.1%)	11 (64.7%)	2 (11.8%)